Understanding Stage 3: Normal vs Optimal Ranges

?What is Stage 3?

Stage 3 is a classification system used in oncology and other disease staging frameworks to indicate intermediate-to-advanced disease severity. The specific meaning depends on the disease context—for example, in cancer staging, Stage 3 typically indicates local or regional spread beyond the organ of origin but without distant metastasis. In chronic kidney disease (CKD), Stage 3 reflects moderate reduction in kidney function with GFR between 30–59 mL/min/1.73m².

!Why It Matters

Stage 3 classification is critical for prognosis, treatment planning, and predicting disease progression and outcomes. Identifying the correct stage early can guide therapeutic decisions and help patients understand the severity of their condition. Stage 3 disease may suggest a need for more intensive monitoring, specialist care, or multimodal treatment approaches compared to earlier stages.

Reference Ranges

Lab normal ranges may vary between laboratories. Optimal and longevity targets are based on research literature and should be interpreted with your physician.

Symptoms of Imbalance

• Symptoms vary widely depending on the underlying disease and organ system affected
• In cancer: pain, fatigue, functional impairment, or organ-specific symptoms
• In chronic kidney disease: fatigue, swelling, reduced urination, or hypertension
• In heart disease: shortness of breath, chest discomfort, or exercise intolerance
• May be asymptomatic in early Stage 3 disease

How to Improve Your Levels

• 1Follow specialist medical treatment plans tailored to the specific Stage 3 diagnosis
• 2Attend regular monitoring appointments and imaging/laboratory assessments
• 3Adopt disease-specific lifestyle modifications (e.g., dietary changes for CKD, activity levels for cardiac disease)
• 4Manage comorbid conditions such as hypertension, diabetes, or anemia
• 5Maintain medication adherence as prescribed by your healthcare team
• 6Seek mental health support and consider joining disease-specific support groups

When to Test

Staging assessment is typically performed at initial diagnosis or when disease progression is suspected. In chronic disease such as CKD, regular testing (often annually or semi-annually) helps track changes in stage. Re-staging may be warranted if symptoms worsen or new clinical findings emerge.

Related Biomarkers